Singapore markets close in 5 minutes
Straits Times Index
3,296.36 -0.53 (-0.02%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,198.43 +26.28 (+0.32%) Bitcoin USD
59,304.39 +1,430.83 (+2.47%) CMC Crypto 200
1,285.27 +8.29 (+0.65%)
Sonnet BioTherapeutics Holdings, Inc. (SONN)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 5.89M |
| Enterprise value | 3.06M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 28.37 |
| Price/book (mrq) | 2.29 |
| Enterprise value/revenue | 23.68 |
| Enterprise value/EBITDA | -0.21 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.12 |
| 52-week change 3 | -64.77% |
| S&P500 52-week change 3 | 21.33% |
| 52-week high 3 | 26.4000 |
| 52-week low 3 | 1.0800 |
| 50-day moving average 3 | 1.8968 |
| 200-day moving average 3 | 2.8187 |
Share statistics
| Avg vol (3-month) 3 | 105.15k |
| Avg vol (10-day) 3 | 14.4k |
| Shares outstanding 5 | 3.07M |
| Implied shares outstanding 6 | 3.07M |
| Float 8 | 2.71M |
| % held by insiders 1 | 9.22% |
| % held by institutions 1 | 3.53% |
| Shares short (15 Apr 2024) 4 | 424.16k |
| Short ratio (15 Apr 2024) 4 | 7.85 |
| Short % of float (15 Apr 2024) 4 | 14.22% |
| Short % of shares outstanding (15 Apr 2024) 4 | 13.82% |
| Shares short (prior month 15 Mar 2024) 4 | 557.46k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 02 Apr 2020 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:22 |
| Last split date 3 | 01 Sept 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Sept 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -6,866.05% |
Management effectiveness
| Return on assets (ttm) | -175.81% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 129.18k |
| Revenue per share (ttm) | 0.07 |
| Quarterly revenue growth (yoy) | -50.00% |
| Gross profit (ttm) | N/A |
| EBITDA | -14.45M |
| Net income avi to common (ttm) | -14.46M |
| Diluted EPS (ttm) | -0.8300 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 3.02M |
| Total cash per share (mrq) | 0.98 |
| Total debt (mrq) | 186.69k |
| Total debt/equity (mrq) | 7.26% |
| Current ratio (mrq) | 1.74 |
| Book value per share (mrq) | 0.84 |
Cash flow statement
| Operating cash flow (ttm) | -18.52M |
| Levered free cash flow (ttm) | -13.56M |
© 2024 Yahoo. All rights reserved.